{"schema_version":"1","generated_at":"2026-10-30T12:33:12.853Z","data_as_of":null,"url":"https://www.findmykol.com/kol/forat-lutfi","json_url":"https://www.findmykol.com/kol/forat-lutfi/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"forat-lutfi","name":"Forat Lutfi","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"city":"Westwood","state":"KS","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1902269335","orcid":"0000-0002-9699-3080","openalex":"A5041058096"},"summary":"Forat Lutfi is a Hematology physician. OpenAlex indexes 158 publications with 663 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":158,"cited_by_count":663,"h_index":14,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":11,"program_years":{"first":2021,"last":null},"rows_total":12,"shown":3,"withheld":9,"rows":[{"payer":"ADC THERAPEUTICS AMERICA, INC.","program_year":2025,"amount_usd":293.45,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902269335"},{"payer":"Celgene Corporation","program_year":2025,"amount_usd":156.88,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902269335"},{"payer":"Janssen Research & Development, LLC","program_year":2025,"amount_usd":146.14,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902269335"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1902269335","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":29,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":29,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":28}]},{"area":"Anti-infectives","share_pct":28.7,"classes_total":3,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":17.8,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":16},{"class":"Sulfone","setting":"prescribed","share_pct":6.3,"drugs":[{"name":"Dapsone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":17.2,"classes_total":3,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":8.6,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":null},{"class":"Corticosteroid","setting":"prescribed","share_pct":5,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":61.1,"facility_pct":38.9},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Autologous Transplant or <scp>CAR</scp>‐T as Consolidation Options in <scp>MYC</scp> Rearranged Large B‐Cell Lymphoma Patients in Remission After Salvage Treatments","year":2025,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.27687","status":"verified"},{"title":"Tarlatamab-induced immune-related adverse events: Retrospective real-world pharmacovigilance study using FAERS database.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e24106","status":"verified"},{"title":"Impact of Systemic Antibiotics Use on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation","year":2025,"journal":"Biology of Blood and Marrow Transplantation","source_url":"https://doi.org/10.1016/j.jtct.2025.01.811","status":"verified"},{"title":"Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel","year":2024,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2023012549","status":"verified"},{"title":"The current socioeconomic and regulatory landscape of immune effector cell therapies","year":2024,"journal":"Frontiers in Medicine","source_url":"https://doi.org/10.3389/fmed.2024.1462307","status":"verified"}],"source":"works"},"contact":{"address_1":"2330 SHAWNEE MISSION PKWY","city":"Westwood","state":"KS","zip":"662052005","phone":"917-225-1359","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1902269335","source":"identity"},"similar":[{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":9,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-08-12","provider_certified":"2025-08-12","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}